U.S. Markets closed

Foundation Medicine, Inc. (FMI)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.50+0.40 (+1.05%)
At close: 4:00PM EDT

38.50 0.00 (0.00%)
After hours: 6:27PM EDT

People also watch
EPZMGHDXXLRNMGNXAGIO

Foundation Medicine, Inc.

150 Second Street
Cambridge, MA 02141
United States
617-418-2200
http://www.foundationmedicine.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees535

Key Executives

NameTitlePayExercisedAge
Dr. Steven Kafka Ph.D.Pres and Chief Operating Officer630.77kN/A48
Mr. Alexis Borisy A.M.Co-Founder, Founding Advisor and Independent Director114kN/A45
Mr. David J. DalyChief Commercial Officer and Gen. Mang. of Clinical Oncology Solutions601.24kN/A55
Mr. Troy CoxChief Exec. Officer and DirectorN/AN/A53
Mr. Jason RyanChief Financial OfficerN/AN/A43
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Foundation Medicine, Inc. provides various molecular information products in the United States. The company’s molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic information about each patient’s individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted oncology therapies. It provides clinical products, such as FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and myeloma, as well as sarcomas and pediatric cancers; Foundation Assay for Circulating Tumor; FoundationFocus CDxBRCA, a diagnostic assay to aid in identifying women with ovarian cancer. The company also offers FoundationCORE, a knowledgebase to publish scientific and medical advances, and foster relationships throughout the oncology community. In addition, it has strategic collaboration agreements with WuXi PharmaTech Inc.; F. Hoffmann-La Roche Ltd.; and Genentech, Inc. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts. Foundation Medicine, Inc. is a subsidiary of Roche Holdings, Inc.

Corporate Governance

Foundation Medicine, Inc.’s ISS Governance QualityScore as of May 1, 2017 is 8. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 4; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.